LINDA CROOM: Open Payments
NPI 1447408042 · CHEVY CHASE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$700 in 18 payments from 12 companies in 2025. Trend: 2023 $3,632 · 2024 $312 · 2025 $700
Food & beverage: $700
| Company | Payments | Amount |
|---|---|---|
| Avadel CNS Pharmaceuticals, LLC | 3 | $166 |
| HARMONY BIOSCIENCES LLC | 4 | $163 |
| JAZZ PHARMACEUTICALS INC. | 1 | $124 |
| Noctrix Health, Inc. | 1 | $52 |
| Axsome Therapeutics, Inc. | 2 | $36 |
| Shionogi Inc | 1 | $27 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| Biogen, Inc. | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Lilly USA, LLC | 1 | $22 |
Products named: LUMRYZ, WAKIX, NIDRA, Sunosi, Fetroja, ZERBAXA, SPINRAZA, FASENRA.
Industry payments across MD — which companies pay providers there.
